SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Pharmaceuticals, Inc. Data to be Presented on Health-Related Quality of Life With Afatinib in Patients With EGFR Mutation-Positive Advanced NSCLC